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Abstract
Translation of mRNAs into protein is an essential mechanism of regulating gene expres-
sion—and a step exploited by viruses for their own propagation. In this article, we review 
mechanisms that govern translation and provide an overview of the translation machin-
ery, discuss some of the components involved in this process, and discuss how viruses 
modulate host translational controls and implications in vaccine design.
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1. Introduction
The central dogma of molecular biology is that data are organized by DNA, mRNA, and 
protein and that this information is translated during transcription leading to the execution 
of cellular programs via proteins, which are fundamental to the functioning of a cell. A vast 
body of literature has added to our understanding of the molecular interplay during trans-
lation; however, it is far from comprehensive as (1) biological systems are complex where 
there is little correlation between the sizes of an organism, its genome size, and the number 
of protein coding/noncoding genes; (2) biological systems respond acutely to changes in the 
environment or upon infection with a pathogen; (3) all biological systems are in a state of con-
tinuous evolution as they learn from new stimuli and adapt accordingly; (4) posttranslational 
modifications are normally required for assembly into molecular complexes/proteins to elicit 
a function; and (5) many proteins are multifunctional across different pathways. We begin 
this article with a succinct overview of the main components involved in protein translation 
and the translation process itself and then consider the multiple roles transfer RNAs (tRNAs) 
have during translation in virus-infected cells and how viruses modify tRNA expression and 
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function. We conclude with a discussion of how understanding the mechanisms by which 
viruses modulate host translation pathway can aid in an effective vaccine design.
Protein synthesis is a multistep process involving various error-checking mechanisms. For 
example, genes are transcribed in the nucleus, and mature messenger RNAs (mRNAs) are 
exported into the cytoplasm as ribonucleoprotein particles, and immediately they are associ-
ated with ribosomes (either free in the cytoplasm or bound to endoplasmic reticulum) for ini-
tiation of translation. In eukaryotes, ribosomes consist of two subunits, a small 40S (Svedberg) 
and a large 60S, which together form 80S macromolecular ribonucleoprotein complexes of 
ribosomal RNA and ribosomal proteins [1]. The 40S subunit scans the mRNA until it recog-
nizes the first codon (triplet AUG) at which point the first amino acid (a.a) methionine (Met) 
which is bound to its cognate transfer RNA (tRNA) with the UAC anticodon enters and binds 
to the AUG codon via sequence complementarity. The 60S subunit binds to this complex form-
ing two distinct pockets, the peptidyl (P) site containing the Met-tRNA and an amino-acyl (A) 
site where the next aa-tRNA comes in. The chain initiator Met from the P site is transferred 
to the a.a. at the A site with the formation of a peptide bond, and the empty tRNA at A site 
is released. The 80S ribosome scans the next codon and the dipeptide-tRNA complex moves 
to the P site, the next aa-tRNA is brought in and peptide chain elongation continues until the 
ribosome reads the special codon (stop codon) that signals chain ending. When stop codons 
are read, the peptide chain from the tRNA and the ribosome is released [2]. Typically, each 
mRNA is processed by multiple ribosomes simultaneously as polysome complexes [3]. Native 
peptides so formed may need substantial posttranslational modifications before they are trans-
ported to their cellular niche and become functional. Mistranslated peptides are degraded by a 
variety of proteolytic mechanisms and components are recycled. Some mRNAs are long-lived 
in the host cytoplasm, while others are rapidly degraded following protein synthesis [4].
2. Principal components of translation
2.1. Ribosomes
Both prokaryotic and eukaryotic ribosomes are macromolecular complexes consisting of ribo-
somal RNAs (rRNAs) and ribosomal proteins. Ribosomes are separated for structural and 
related studies using isopycnic ultracentrifugation [5] where eukaryotic ribosomes typically 
pellet at 80 Svedberg units of sedimentation and are referred to as 80S ribosomes though they 
consist of the smaller 40S and the larger 60S subunit [6–11]. The complete ribosome is 4.3 MDa 
where the larger 60S subunit contains 28S rRNA, 5S rRNA, 5.8S rRNA, and 47 distinct ribo-
somal proteins, while the smaller 40S contains a single 18S rRNA and 33 distinct ribosomal 
proteins [12]. Mammalian ribosomes contain all the sites necessary for interaction with the 
components of the translation machinery such as eukaryotic initiation factor 1 [13]. Structural 
studies have identified conserved cores in mammalian ribosomes as well as proteins that are 
unique to the human ribosome [14]. The main features of the ribosome involved in translation 
include the amino-acyl (A) site where aa-tRNAs bind, the P site where peptide bond forma-
tion occurs, and the E site where uncharged tRNAs exit the ribosome (Figure 1). Ribosomal 
RNAs are also posttranscriptionally modified at multiple positions and these modifications 
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are essential for proper folding and function [15, 16]. Typical rRNA modifications are cata-
lyzed by small nucleolar RNAs (snoRNAs) and include 2’-O ribose methylation and pseu-
douridylation, which is a very abundant posttranscriptionally modified nucleotide in various 
stable RNAs of all organisms. These specific bases in the rRNA stabilize rRNA structure and 
function. Ribose modifications are guided by C/D box snoRNAs, while pseudouridylation 
modifications are regulated by H/ACA box snoRNAs [17–24].
Figure 1. Overview of host translation.
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2.2. Messenger RNA (mRNA)
The human genome is 3.4 billion base pair long and encodes ~32,000 protein-coding genes 
with a median gene size of ~1 kb containing 7 exons [25]. Protein-coding genes are transcribed 
by RNA polymerase II, and primary transcripts are spliced to remove introns to generate 
mature mRNAs, which are polyadenylated by a poly A polymerase at the 3′ end while the 5′ 
end carries a specific 7-methyl guanosine (m7G) modification that stimulates canonical trans-
lation initiation [26]. Mature mRNAs associate with several RNA-binding proteins and exit 
the nucleus as ribonucleoprotein complexes, which then associate with ribosomes to initiate 
translation. Multiple factors such as number of transcripts, half-life of the mRNA, etc. deter-
mine the level to which a particular mRNA is translated. Housekeeping mRNAs have long 
half-lives, while transcription factors and inducible genes constitute the bulk of mRNAs with 
short half-lives in concordance with their transient roles.
2.3. Transfer RNAs
The human genome encodes 610 tRNA genes [25] that are interspersed throughout the nuclear 
genome and can be classified into 51 anticodon families targeting the 64 codons. Significant 
intraspecies [26] and interspecies [25] copy number variation has been previously demon-
strated and may extend to the tissue or cellular level. Approximately 50% of the nuclear tRNA 
genes are transcribed. The standard 20 a.a are decoded by 597 different tRNAs, and 3 tRNAs 
encode selenocysteine, where incorporation of selenocysteine into the growing peptide chain 
occurs by a unique suppressor tRNA and a stop codon. Moreover, 2 tRNAs have potential 
suppressor function, and 6 tRNAs have unknown a.a. that they carry. Additionally, the 
mitochondrial genome encodes 22 mitochondrial tRNAs (mtRNAs) [27]. Nuclear tRNAs are 
encoded by intronic or intergenic tRNA genes that are transcribed by RNA polymerase III in 
conjunction with transcription factors TBP, BDP1, BRF1, TFIIIB, and TFIIIC in a 3D spatially 
distinct region in the nucleus termed the nucleolus.
The prototypical tRNA genes consist of a 5’-UTR and signature A and B box motif [28, 29], fol-
lowed downstream by a stretch of U residues that signal transcript termination. tRNA genes can 
be located within introns of protein coding genes where they are cotranscribed with their encod-
ing genes. For all intergenic tRNAs, transcription is a concerted process initiating with binding 
of transcription factor TFIIIC to the A and B box region, recruiting TFIIIB upstream, and cul-
minating in recruitment of RNA Pol III. Primary transcript is next processed by RNAse P- and 
RNAse Z-mediated removal of the 5′ leader and the 3′ trailer sequence, where tRNA nucleotidyl 
transferase mediates addition of the 3’-CCA trinucleotides [30–32]. Several posttranscriptional 
modifications on the tRNA are followed by coupling of the tRNA with the cognate a.a., a pro-
cess mediated by aminoacyl tRNA synthetases. The process of tRNA charging involves recogni-
tion of several modifications on the tRNA body especially N73 near the CCA motif at the 3′ end 
[33]. Aberrant primary tRNA transcripts are recycled through a nonsense-mediated decay path-
way involving degradation of their 3′ ends. Additionally, mature tRNAs lacking modifications 
are degraded via a 5′ exonucleolytic cleavage. Eukaryotic cells encode for 20 distinct tRNA syn-
thetases for each of the 20 standard a.a. It remains unclear if amino acylation is restricted to the 
nucleus or also occurs in the cytoplasm. Mitochondrial tRNAs (mtRNAs) that are encoded on 
the circular mitochondrial genome between the rRNA and mRNA genes [27] are transcribed by 
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the mitochondrial RNA polymerase in conjunction with transcription factors Tfam and mtTFB 
from the bidirectional promoters on the circular mitochondrial genome.
Both cytosolic and mtRNAs are posttranscriptionally modified [34], though nuclear tRNAs [35] 
can have additional modifications presumably due to the mechanisms of action for nuclear 
tRNAs and the bacterial origin of mitochondrial tRNAs [27, 36, 37]. These modifications have at 
least three important functions: (1) modifications affecting the anticodon loop, which alter trans-
lation efficiency; (2) modifications to the tRNA body affecting tRNA secondary structure; and 
(3) modifications at other positions that determine aminoacyl transferase recognition and amino 
acid loading on the CCA motif [38]. More than 100 diverse modifications have been reported for 
nuclear tRNAs, while mtRNAs exhibit about 16 conserved posttranscriptional modified nucleo-
sides [39]. The nature and role of tRNA modifications are beyond the scope of this review, 
but they have an essential role in tRNA function both canonical and noncanonical functions. 
Specifically, modifications in the anticodon loop affect tRNA translational function and increase 
translational accuracy by preventing translational frameshifting. Posttranscriptional modifica-
tions to tRNAs considerably increase tRNA complexity since the presence/absence of certain 
modifications can affect tRNA function, and it is estimated that the major tRNA modifications 
can lead to 8192 possible different species of tRNAs for each tRNA. Most mature nuclear tRNA 
molecules are ~76–93 nts, while mtRNAs are 57–73 nts. Nuclear tRNAs exhibit an evolution-
arily conserved cloverleaf secondary structure across pro- and eukaryotic kingdoms consisting 
of four arms designated the acceptor arm, dihydrouridine arm, anticodon stem loop, and the 
TψC arm (ψ representing pseudouridine). The 3′ end of all tRNA molecules terminates in a CCA 
sequence, the 2′ or 3’-OH of the terminal adenosine being the site of aminoacyl-tRNA addition. 
In 3-D, tRNA molecules assume an L-shaped structure where the TψC arm stacks on the accep-
tor stem to form a 12 bp acceptor-TψC minihelix flanking the anticoding stem loop. mtRNAs 
can be structurally classified into three classes [40]: (1) class I mtRNAs (e.g., tRNASer(UCN)), which 
contain a short and an extended anticodon stem [40], (2) class II mtRNAs lack the canonical D- 
and T-loop interaction and have variable lengths and are stabilized via an interaction between 
the D-stem and the extra loop [41, 42], and (3) class III mtRNAs (e.g., mtRNASer(AGY)) lack the 
D-loop and do not exhibit the classical cloverleaf structure [43, 44].
2.4. Wobble-hypothesis and associated implications on translation
The specificity of the codon: anticodon interaction is crucial for incorporation of the correct amino 
acid into the growing peptide chain and determines the composition of the proteome [45–47], rate 
of a.a misincorporation [48–52], and ultimately protein folding [53, 54]. However, the standard 
genetic code is degenerate (i.e., more than one codon can specify the same amino acid). For exam-
ple, six different codons can specify the a.a. lysine (K); tRNALys is thus able to bind to six different 
codons for K in any given mRNA. This is because the ribosome can determine if the interactions 
between the first two bases of the anticodon on the tRNA and the corresponding complements 
on the mRNA are of Watson-Crick-type, but cannot distinguish if the third base interaction is 
perfectly complementary. Nuclear magnetic resonance (NMR) studies with anticodon stem loops 
of the smaller 40S unit of E. coli tRNALys have clearly shown three modifications in this region, 
a N6-threonylcarbamoyladenosine (t6A) modification at position 37, a 5-methylaminomethyl-
2-thiouridine (S,mnm5s2U) modification at position 34, and a pseudouridine at position 39, which 
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force the dynamic loop structure to assume an open U-turn structure that perfectly fits the ribo-
somal decoding center [55]. Ribosomal profiling studies have shown that wobble positions slow 
the rates of protein translation [56]. Controlling the rate of translation via wobble base pairing has 
important implications: (1) utilizing infrequent tRNAs that are expressed only under particular 
stimuli, (2) allowing for stable and correct folding of the protein, and (3) allowing information for 
regulation of translation rate to be hard-coded in the mRNA [57, 58].
Recent studies have shown that in cellular organelles that do not encode all the tRNAs neces-
sary to read the genetic code, a single tRNA species containing a U in the wobble position in 
the anticodon can read fourfold degenerate codon, a phenomenon described as superwob-
bling [58]. The superwobbling allows codons to be decoded not only by tRNAs containing a 
perfectly complementary or wobble 3rd base but also by tRNAs that employ superwobbling 
allowing for smaller genomes [58, 59].
2.5. Alternative functions of tRNAs
In addition to their normal function in protein synthesis, tRNAs acutely respond to cellular and 
environmental stresses. Cells with different proteomic profiles also exhibit diversity of tRNA 
iso-acceptor types, i.e., tRNAs with different anticodons but same a.a. tRNA expression, post-
transcriptional modifications, and abundance (both copy numbers and expression) typically 
reflect the cellular state of tRNAs that code for the most abundant codons and are found in high 
copy numbers. tRNA expression levels in a particular cell type reflect the codon bias of that cell 
and indicate the proliferation status of a cell type, a feature that supports the proposition that 
tRNA gene expression is modulated in response to the host cell needs. The ribosomal tempo 
is thus regulated by abundance and diversity of the tRNA pool available during translation.
tRNAs are cleaved during cellular stress [60] and in immune response to infection generating 
specific tRNA fragments (tRFs) that contain the 5′ (5’tRFs) or the 3′ (3’tRFs) ends of the parent 
tRNA molecule (Figure 2). The most known tRFs are nuclear in origin though a few tRFs have 
been shown to originate from plastid genomes [61] or mitochondria [62]. tRFs have also been 
reported to originate from the pre-tRNA moiety instead of the mature tRNA molecule, and these 
are labeled as 3’-U tRFs since they match the 3′-trailer region of the precursor tRNA [63–65]. 
Many tRFs that result from cellular stress conditions consist of two 30–40 nt long fragments split 
across the anticodon loop and are referred to as tRNA-derived stress-induced RNAs (tiRNAs) 
[66–68]. tiRNAs reflect universal hallmarks of cellular stress across all kingdoms of life [69–75].
The level of parent tRNA molecules is maintained during tRF generation suggesting that tRF 
formation may be a mechanism to regulate translation via inhibition of initiation [76, 77]. Among 
tRFs, 5’-tRFs primarily function as signaling intermediates [78] and reduce translation [79] via 
induction of stress granule formation [80]. The complete biosynthesis of tRFs involves either 
degradation of pre-tRNA molecules via the TRAMP pathway in the nucleus [81–85] or via cyto-
solic degradation of mature tRNAs via the rapid tRNA decay (RTD) pathway. The TRAMP 
pathway consists of a polyadenylase Trf4 (topoisomerase 1-related 4), a RNA helicase Mtr4p 
(mRNA transport regulator 4 protein), and Air2 (arginine methyltransferase-interacting RING 
finger protein 2), which interacts with Rrp6, a 3′ exoribonuclease of the nuclear exosome. The 
RTD pathway involves methionine-requiring protein 22 (Met22) [86] and cytosolic 5′-3′ exonu-
cleases such as ribonucleic acid trafficking protein 1 (Rat 1) [86], exoribonuclease 1 (Xrn1) [86, 87], 
endonucleases ELAC2 [65], Dicer [64, 88, 89], and angiogenin (ANG) [71]. Though the exact 
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function of tRFs is not known, evidence indicates that tRFs can behave as siRNAs by degrad-
ing transcripts [90] and can regulate ribosomal loading and protein chain elongation [91]. 
Mechanisms of how tRFs are produced are most likely stimulus and species specific. Similarly, 
the functional roles of tRFs are yet to be elucidated (reviewed previously [92]). In yeast, tRFs 
are associated with starvation-induced vacuoles where they are degraded to provide phosphate 
and nitrogen [93]. tRFs also accumulate in plants during conditions of phosphate paucity [70]. 
Cleavage of the 3′ end CCA by angiogenin has been shown to reduce rate of protein translation 
[94], as well as initiation by competing with the eukaryotic initiation factor eIF4F.
2.6. How do tRNAs affect vaccine production and potentially efficacy?
Among the variety of stimuli host cells respond to, intracellular pathogens are a special case as 
many pathogens regulate host cell translation themselves. Viruses in particular regulate mul-
tiple facets of the host translation process since inhibition of host protein synthesis (1) makes 
Figure 2. Transfer RNA structure and biogenesis of transfer RNA fragments (tRFs). The cloverleaf model of a canonical 
nuclear tRNA is shown. Bold lines indicate Watson-Crick base pairing in the tRNA stems while dotted lines indicate 
base pairing in the tertiary structure of the tRNA. Shaded areas indicate regions from where the 5’/ 3’ or internal tRFs 
are produced.
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available crucial resources for translation of viral proteins, (2) reduces intracellular antiviral 
responses, and (3) reduces intercellular signaling helping viral spread in neighboring tissue. 
Immunization of a host with viral vaccine antigen can prevent viral modulation of the host 
translation machinery. Most viral antigens are considered “foreign” by the host cell—a feature 
tied to their codon usage that differs from the host.
The standard vertebrate genetic code contains 64 codons (61 coding for an amino acid and 3 
stop codons); however, most eukaryotic proteins contain 20 standard amino acids, and thus, 
more than one codon can encode the same amino acid. Codons that specify the same amino 
acid are referred to as synonymous codons. Those that do not specify the same amino acid are 
termed nonsynonymous codons. However, most biological systems have evolved to preferen-
tially utilize one or few codons for each amino acid during translation, a feature referred to as 
codon usage bias [95–98]. Thus, in an infected cell, viral and host proteins may be translated 
by very different collections of codons. Accumulating data show that many viruses evolve 
to adapt their codon usage to the host [99], and this can be specific for each virus or viral 
gene to regulate the tempo and pattern of expression. This raises a challenge in commercial 
vaccine production because rare codon usage can lead to low yield of the immunogen and 
increase production costs [100]. Secondly, while most host protein synthesis begins with an 
initiator codon (AUG) coding for methionine, viral genomes utilize multiple mechanisms of 
noncanonical translation such as internal ribosomal entry sites (IRES), ribosome shunting, 
leaky scanning of the viral open reading frame, non-AUG initiation, and reinitiation from 
AUG with frame shifts; read through translation and alternative stop; and carry on translation 
[101]. A detailed description of this is out of the scope of this examination, and it is important 
to understand how these mechanisms can be used to improve vaccine yield and/or efficacy.
A commonly employed strategy to improve vaccine yield is to optimize the codon usage pat-
tern to overcome bias for the antigen in question [57, 102]. Codon usage bias is calculated by 
counting the number of time a particular codon is observed in a gene or set of genes. This can 
be extended to calculate the relative synonymous codon usage, which reflects the abundance 
of a particular codon relative to all other codons in the absence of a codon usage bias. By tabu-
lating the most frequently used codons in the host genome and comparing to those used in 
the viral genome, it is possible to discern codon usage bias (CUB) for the virus. Immunogens 
in vaccines can then be expressed either in cells that overexpress the rare tRNA used by the 
viral protein to increase protein yield or engineered through molecular tools (site-directed 
mutagenesis, cloning, etc.) to utilize the most common host codons. This codon optimization 
strategy has been employed for developing a variety of vaccines [57, 103–140]. Codon optimi-
zation has been reported to reduce vaccine efficacy by increasing antigenicity and changing 
conformation of the native immunogen [141–145]. Codon optimization as a way to increase 
immunogen (vaccine) production suffers from the assumptions that: (1) rare codons limit rate 
of translation, (2) synonymous codons have redundant function, (3) replacing rare codons 
with high-frequency codons improves protein yield, and (4) sites of posttranslational modifi-
cations are preserved upon codon optimization. However, multiple studies have shown that 
these are not necessarily true and multiple other factors such as mRNA secondary structure 
[146] and posttranscriptional modifications on mRNAs [147] can alter rates of translation.
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Conversely, incorporation of rare (nonpreferred) codons in viral genes used for antigen 
production can lead to decreased production of viral antigens and lead to attenuation. This 
codon deoptimization strategy has also been employed for a variety of viral vaccine can-
didates [148–163]. These studies have clearly shown attenuation of viral replication and 
improved immune responses. Further, it was recently shown that deoptimized live attenu-
ated viral vaccines in case of respiratory syncytial virus (RSV) remain genetically stable if 
these changes in the genome are distributed throughout and not restricted to one viral gene 
or antigen [149]. Codon deoptimization strategies are still being explored for viral vaccine 
design; however, like codon optimization strategies, the rules for design of a safe and effec-
tive candidate are only partly recognized. Both optimization and deoptimization require 
extensive computational analysis, which needs to be followed up with measures of attenua-
tion, antigenicity, and structural analysis of the antigen coupled with analysis of alternative 
peptides and proteins. An overview of codon optimization strategies currently used for viral 
antigens is shown in Figure 3.
Figure 3. Strategies for codon optimization for viral gene expression. Schematic showing how poor translation of viral 
antigens owing to differential codon usage between viral and host genes can be overcome. In all panels, host/viral 
codon usage for six hypothetical amino acids (aa1–6) is shown using a color-coded histogram. Each bar represents a 
separate codon (1–4) used for that amino acid. Height of the bar is proportional to the frequency of that codon used. 
Host histograms are distinguished by bold outlines. (A) In this approach, the entire viral coding sequence is modified to 
reflect the most abundant codons used by the host. (B) In this strategy, only those viral codons that are rare in the host are 
mutated to the host codon. (C) In this approach, viral coding sequences are mutated to reflect optimum (not necessarily 
maximal) codon usage (D) This approach utilizes information on host transfer RNA (tRNA) expression to determine 
which codons in the viral coding sequence need to be mutated to the host. This strategy can include/exclude host codon 
usage bias. Host tRNA expression is depicted on a color scale with low (black) to red (high) expression.
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3. Future directions
tRNAs and other molecules involved in host translation are an important target for disease 
intervention especially for intracellular viral pathogens, which are completely reliant on the host 
translation machinery for their successful replication and propagation in the host. However, 
mechanisms by which viruses and their hosts regulate translation are still being elucidated and 
this information is critical for development of novel interventions for both infectious and nonin-
fectious diseases. Several vaccine production platforms use codon optimization strategies so that 
vaccine candidates mimic host codon usage and can be produced more efficiently with lower 
production costs. This results in selective usage of certain tRNAs to carry particular amino acids 
and to be recognized by the host cells. It is important that viral proteins can be synthesized pref-
erentially over host proteins stimulating an immune response using these viral antigens and can 
be used to educate the host immunity to reduce or block damage due to subsequent infections. 
Inherently, every vaccine is foreign in nature for its host, which triggers an immune response. 
Prevalent vaccines used against infectious disease broadly fall into three categories: (1) those 
involving attenuated/killed pathogen, (2) subunit vaccines that contain one or more pathogen 
antigens (pathogen-derived or recombinant), and (3) recombinant plasmids that express one 
or more antigens as above. Additionally, vaccines are formulated considering delivery routes, 
speed of antigen release, need for adjuvants, and desired immune response. Irrespective of 
these criteria, the primary criterion that defines a vaccine is its antigenicity and it is important to 
understand mechanisms that regulate antigenicity of vaccine candidates to retain efficacy in vivo.
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